Addex Therapeutics to Participate in Bio-Europe 2023 Conference and Release Financial Results

Addex Therapeutics, a clinical-stage pharmaceutical company, will participate in the Bio-Europe 2023 Conference. They will also release their Half-Year 2023 Financial Results on August 10, 2023. Additionally, they have extended their collaboration agreement with Indivior PLC for the discovery of novel oral GABAB positive allosteric modulator (PAM) drug candidates for the treatment of substance use disorder.